|
Agilent in Life Sciences
|
|
Agilent tools help scientists to understand complex biological processes,
unlock the causes of disease and speed the discovery of new drugs.
Agilent provides products for customer needs throughout the entire
pharmaceutical value chain from basic research to drug manufacturing.
|
|
Markets |
Agilent’s life sciences business addresses the needs of four key markets:
gene expression, proteomics, informatics, and pharmaceutical analysis. |
|
Gene expression research enables scientists to compare the
gene activity of diseased versus healthy cells, providing insight
into the genetic causes of disease. Agilent is second leading provider
of gene expression solutions, with more than 500 customers worldwide.
|
|
Proteomics encompasses the large-scale study of proteins,
including protein identification and characterization. Agilent provides
complete liquid chromatography/mass spectrometry-based solutions for
protein identification, from protein isolation through data analysis,
as well as protein LabChips for protein quality assessment. |
|
Informatics enables scientists to pull together disparate
sets of biological data and analyze the information. Agilent offers
a range of informatics solutions spanning applications in gene expression,
genotyping and protein identification. The anticipated acquisition
of Silicon Genetics positions Agilent as a market leader in this field.
|
|
Agilent is a market leader in pharmaceutical analysis , which
focuses on the later stages of the pharmaceutical value chain including
drug development, QA/QC and manufacturing. Agilent provides instrumentation,
data systems and compliance services that are designed to meet the
requirements of the regulated lab. |